Multidisciplinary care to advance metastatic colorectal cancer treatment
asthma atopic dermatitis autoimmune biosimilar breast cancer COPD COVID-19 (new coronavirus infection) cardiovascular bile duct cancer chronic kidney disease colorectal cancer DLBCL Dermatology Diabetes digital health Duchenne muscular dystrophy employer epilepsy gene therapy HIV heart failure hemophilia tumor immunology Infection inflammation leukemia and lymphoma liver lung cancer lupus major depressive disorder medicare multiple myeloma multiple […]
Targeted Oncology Metastatic Colorectal Cancer: Treatment Strategies and Hope for Patients An expert perspective on comprehensive treatment strategies for metastatic colorectal cancer, including systemic therapy, precision medicine….50 minutes ago
Targeted Oncology Metastatic Colorectal Cancer: Treatment Strategies and Hope for Patients An expert perspective on comprehensive treatment strategies for metastatic colorectal cancer, including systemic therapy, precision medicine….50 minutes ago
Study finds that tumor debulking does not affect quality of life in patients with metastatic colorectal cancer
New research in October 2023 issue JNCCN-;National Comprehensive Cancer Network Journal In addition to standard systemic therapy, intensive local treatment to remove as much tumor as possible (known as “debulking”) can have a significant impact on the overall quality of life of patients with metastatic colorectal cancer. I discovered that it doesn’t give. Researchers looked […]
Comprehensive treatment strategy may change prognosis for patients with metastatic colorectal cancer
Treatment and prognosis of colorectal cancer with synchronous peritoneal metastasis. Credit: Xiusen Qin, Zifeng Yang, Yang Li, Jian Luo, Hui Wang, Huaiming Wang Colorectal cancer (CRC) with synchronous peritoneal metastases (SPM) is a difficult disease to treat and has a relatively poor prognosis. However, recent advances in treatment strategies have improved outcomes for patients with […]
Japan seeks approval of fruquintinib for previously treated metastatic colorectal cancer
Colorectal cancer © Stock.adobe.com A new drug application (NDA) has been submitted to Japan’s Ministry of Health, Labor and Welfare seeking approval of fruquintinib (Elnato) for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC).1 The NDA is supported by data from the Phase 3 FRESCO-2 study (NCT04322539) and results from the […]
Cetuximab maintenance therapy may be effective in RAS wild-type metastatic colorectal cancer
bookmark 1. In this randomized phase 2 clinical trial, patients with metastatic colorectal cancer who received cetuximab maintenance therapy had median progression-free and overall survival compared with patients who received observation only during the maintenance phase. The values were found to be improving. 2. There were no statistical differences in adverse events when comparing controls […]
New treatment option for metastatic colorectal cancer extends survival | VUMC Reporter
Written by Tom Wilemon A new treatment is on the horizon for patients with metastatic colorectal cancer who have run out of treatment options. Results of international clinical trials, Posted on June 15th lancetshowed that fruquintinib, a selective targeted therapy, resulted in statistically significant improvements in overall survival and progression-free survival. Median survival for patients […]